美国纽约大学药学院招聘细胞生物学方向博士后
2014-12-31 10:26 来源: 未知 作者: liuxuehr
The laboratory of Dr. Xue-Ru Wu at the New York University School of Medicine has a longstanding and intense interest in defining the molecular drivers of urothelial tumors (bladder cancer) along divergent pathways. This interest is being pursued through the development and analyses of genetically engineered mice (transgenic, knockout and knock-in), high-throughput profiling, in vitro overexpression and knockdown as well as corroborative studies using human specimens. Presently funded by the US National Institutes of Health and Veterans Administration, Dr. Wu’s group is taking a multidisciplinary approach involving several well-established investigators with expertise in animal modeling, signaling transduction and DNA damage and repair. The group provides postdoctoral fellows with unique opportunities to be exposed to a broad range of techniques and collaborative projects.
Postdoctoral positions are immediately available in Dr. Wu's lab to study the molecular players and their interactions that drive urothelial tumor formation and progression. Individuals with Ph.D. and/or MD with at least one year of research experience are encouraged to apply. Interested candidates should email a cover letter, CV and contact information for three referees to
xue-ru.wu@nyumc.org
Postdoctoral positions are immediately available in Dr. Wu's lab to study the molecular players and their interactions that drive urothelial tumor formation and progression. Individuals with Ph.D. and/or MD with at least one year of research experience are encouraged to apply. Interested candidates should email a cover letter, CV and contact information for three referees to
xue-ru.wu@nyumc.org
声明：凡本网注明"来源：XXX"的文/图等稿件，本网转载出于传递更多信息及方便产业探讨之目的，并不意味着本站赞同其观点或证实其内容的真实性，文章内容仅供参考。如其他媒体、网站或个人从本网站转载使用，须保留本网站注明的“来源”，并自负版权等法律责任。作者如果不希望被转载或者联系转载等事宜，请与我们联系。
